Marinos Dalakas
National and Kapodistrian University of Athens
H-index: 124
Europe-Greece
Top articles of Marinos Dalakas
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Post-COVID Small Fiber Neuropathy, Implications of Innate Immunity, and Challenges on IVIG Therapy | Marinos C Dalakas | 2024/4/17 | |
Therapies in stiff-person syndrome: advances and future prospects based on disease pathophysiology | Marinos C Dalakas | 2023/4/14 | |
Advances in the therapeutic algorithm for myasthenia gravis | Marinos C Dalakas | 2023/7 | |
Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria | Annals of Clinical and Translational Neurology | Nicholas H Chia Andrew McKeon Marinos C Dalakas Eoin P Flanagan James H Bower | 2023/7 |
First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a … | Neurological Sciences | Charalampos Skarlis Nikolaos Markoglou Maria Gontika Anastasia Bougea Serafeim Katsavos | 2023/2 |
Author Response: Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy | Marinos C Dalakas Ubaldo Martinez-Outschoorn Goran Rakocevic | 2023/6/12 | |
N2 Year in Review | Josep Dalmau Marinos C Dalakas Dennis L Kolson Friedemann Paul Raquel Sánchez-Valle | 2023/1/3 | |
Severe Stiff-Person Syndrome After COVID: The First Video-Documented COVID Exacerbation and Viral Implications | Neurology: Neuroimmunology & Neuroinflammation | Marinos C Dalakas | 2023/12/26 |
Autoimmune inflammatory myopathies | Marinos C Dalakas | 2023/1/1 | |
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review | Agustí Alentorn Giulia Berzero Harry Alexopoulos John Tzartos Germán Reyes Botero | 2023/5/25 | |
Late-onset stiff-person syndrome: challenges in diagnosis and management | Therapeutic Advances in Neurological Disorders | Marinos C Dalakas Jessica Yi | 2023/12 |
Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy? | Felix Kohle Marinos C Dalakas Helmar C Lehmann | 2023/1 | |
Late-onset Stiff Person Syndrome (SPS): Challenges in Diagnosis and Management (P4-5.017) | Jessica Yi Marinos Dalakas | 2023/4/25 | |
Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: what we learnt from consensus criteria in CIDP, myasthenia gravis and … | Marinos C Dalakas | 2023/9 | |
Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a … | Naunyn-Schmiedeberg's Archives of Pharmacology | Maria Gontika Charalampos Skarlis Nikolaos Markoglou Dimitrios Tzanetakos Aglaia Vakrakou | 2022/8 |
Peripheral neuropathy evaluations of patients with prolonged long COVID | Neurology: Neuroimmunology & Neuroinflammation | Anne Louise Oaklander Alexander J Mills Mary Kelley Lisa S Toran Bryan Smith | 2022/3/3 |
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis | Marinos C Dalakas Andreas Meisel | 2022/4/3 | |
Evolution of anti-B cell therapeutics in autoimmune neurological diseases | Panos Stathopoulos Marinos C Dalakas | 2022/4/1 | |
Long-term effectiveness of IVIg maintenance therapy in 36 patients with GAD antibody–positive stiff-person syndrome | Neurology: Neuroimmunology & Neuroinflammation | Jessica Yi Marinos C Dalakas | 2022/7/7 |
Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations | Marinos C Dalakas Norman Latov Krista Kuitwaard | 2022/11/2 |
